COVID is less severe with Omicron than Delta, U.S. study suggests

Indonesia Berita Berita

COVID is less severe with Omicron than Delta, U.S. study suggests
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 ReutersScience
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta wave, with shorter hospital stays, less need for intensive care and fewer deaths, according to a new U.S. study.

However, the fast-spreading Omicron variant has led to record numbers of infections and hospitalizations, straining the U.S. healthcare system.

Deaths in the period from Dec. 19 to Jan. 15, when Omicron infections were at a peak, averaged 9 per 1,000 COVID cases, compared to 16 per 1,000 in the previous winter peak and 13 during the Delta wave, the study showed. Relatively high hospitalizations among children during the Omicron period may be related to lower vaccination rates compared with adults, the agency said. Children under age 5 are not yet eligible for vaccines in the United States and the rate of vaccination among older children lags that of adults.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

ReutersScience /  🏆 559. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer opens study of COVID shots updated to match omicronPfizer opens study of COVID shots updated to match omicronPfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer...
Baca lebih lajut »

Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyPfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Baca lebih lajut »

Pfizer opens study of COVID shots updated to match omicronPfizer opens study of COVID shots updated to match omicronPfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
Baca lebih lajut »

Pfizer opens study of COVID shots updated to match omicronPfizer opens study of COVID shots updated to match omicronThe original vaccines still offer good protection against severe illness and death. Studies in the U.S. and elsewhere have made clear that adding a booster dose strengthens that protection and improves the chances of avoiding a milder infection.
Baca lebih lajut »

COVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakCOVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakNew Zealand Prime Minister Jacinda Ardern revealed that her own wedding will be postponed as she announced a new set of COVID-19 restrictions amid the country’s first omicron outbreak.
Baca lebih lajut »

Fauci: Omicron COVID-19 infections likely to peak in FebruaryFauci: Omicron COVID-19 infections likely to peak in FebruaryDr. Anthony Fauci said he was 'as confident as you can be' that states will hit their highest point of infections in February
Baca lebih lajut »



Render Time: 2025-04-16 07:33:31